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Introduction
Currently 60% of all colorectal cancer patients in the UK undergo major surgery [1]. Of these, 
22% of patients are aged 80 years or older [2]. Not all older patients undergo surgery and as patient 
age increases, the numbers of those undergoing surgical resection declines. Less than 40% of patients 
aged over 85 years were offered surgical resection in 2013 (11.5% of all diagnoses of colorectal cancer 
in the UK). However, of those patients aged 85 years and older who did undergo surgery, 42% were 
alive at 2 years [1] postoperatively.
Older patients are chronically underrepresented in colorectal surgical studies [3,4]. Furthermore, 
the majority of available current evidence is focussed upon those who undergo surgical intervention. 
There is much less evidence pertaining to the non-operative management of older surgical patients 
with colorectal cancer. No studies, to our knowledge, have reviewed outcomes of the very elderly 
who are managed non-operatively [5]. As such, whilst data are available and accessible as to the 
risks, complications and potential outcomes of surgical intervention (such as validated online risk 
calculators e.g. www.riskcalculator.facs.org), it is much more difficult to counsel patients through 
the decision to proceed with non-operative management in terms of complications, outcomes and 
prognosis. 
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Abstract
Introduction: Sixty percent of all colorectal cancer patients in the UK undergo major surgery. Of 
these, 22% of patients are aged 80 years or older. Historically there has been a tendency to exclude 
very old patients from entering clinical trials (not just those within surgery), making evidence based 
clinical decision making more challenging [3]. It is difficult, therefore, to accurately guide this group 
of patients who have been assessed as fit for surgery. This is the first study to assess the outcomes for 
all older patients with colorectal cancer, regardless of whether they underwent surgical intervention 
or not.
Methods: Clinical case notes and electronic patients records were retrospectively reviewed for all 
patients admitted to North Bristol NHS Trust over a five-year period (January 2009 to February 
2014). Patients presenting with a new diagnosis of colorectal cancer were identified. All patients 
aged 85 years and over were included in the study. Patients were stratified by clinical management 
strategy i.e. operative or non-operative management of their colorectal cancer. Primary outcome 
measure was overall survival.
Results: There were 199 patients included in the study, 50.8% (101) were male. Median age of all 
patients was 88 years (range 85-97 years) and 47% of all patients underwent surgery. More than half 
(57%) underwent right-sided resections (including hepatic flexure). Overall mean survival for non 
acute presentations of colorectal cancer were longer in both the operative group and non operative 
groups (p = 0.007 and p = 0.03 respectively). There was no difference between mean survival in 
patients presenting as acute surgical emergencies irrespective of operative or non-operative 
management (p = 0.31).
Conclusion: A third of patients with colorectal cancer present as an acute surgical emergency. 
For this group of patients prognosis is poor and there does not appear to be a survival benefit in 
undergoing surgical resection.
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There are much improved pharmacotherapy for the management 
of chronic medical conditions affecting older surgical patients and 
generally a greater awareness of an ever increasing ageing population 
and resulting challenges faced in managing these high risk patients. 
Traditionally, patients over the age of 80 years undergoing segmental 
colonic resection have been less likely to receive adjuvant therapies 
or additional surgery (for recurrence or metastatic disease) following 
their diagnosis of colorectal cancer when compared to patients under 
the age of 80 years [6,7]. However, studies have supported that even 
very frail older people can be offered tailored colorectal chemotherapy 
regimens safely [8]. It is therefore important to estimate survival in all 
older people with colorectal cancer irrespective of the intention for 
operative or non-operative management to aid in clinical decision 
making and counselling patients.
This study aimed to characterise the range of treatment options 
offered and mortality in a very elderly population presenting 
with colorectal cancer irrespective of operative or non-operative 
management.
Methods
Clinical case notes and electronic patients records were 
retrospectively reviewed for all patients admitted to North Bristol 
NHS Trust over a five-year period (January 2009 to February 2014). 
North Bristol NHS Trust is a large NHS Trust in the South West of 
England. This study examined information currently collected as 
part of routine care. As such, the study was deemed to be service 
evaluation and did not require ethical approval.
Patients presenting with a new diagnosis of colorectal cancer were 
identified. All patients aged 85 years and over were included in the 
study. These included patients presenting as an emergency, and those 
referred from primary and secondary care. Patient demographics, 
type of presentation (acute or non-acute) and tumour site (right sided, 
left sided, rectal) were all recorded. Patients were stratified by clinical 
management strategy i.e. operative or non-operative management 
of their colorectal cancer. Factors contributing to clinical decision 
making for operative and non-operative management were also 
recorded e.g. patient choice, inoperable disease, and overall fitness for 
surgery.
Primary outcome measure was overall survival. Secondary 
outcome measures were post operative complications and length of 
hospital stay (recorded as whole-day integers, with any part of a day 
rounded upward).
Statistical analysis was carried out using SPSS version 22. 
Continuous data are summarised as mean and median values and 
categorical data as frequencies with percentages. Comparisons were 
performed using chi squared testing and independent t tests.
Results
A total of 199 patients were included in the study. 50.8% (101) 
of patients were male. Median age of all patients was 88 years (range 
85-97 years). More than half of all patients (53%) included in the 
study were managed non-operatively. There was greater frequency of 
new colorectal cancer diagnoses referred by primary and secondary 
care services on a non-acute basis (64%) than as an acute surgical 
emergency. Patients who underwent surgery (acute or non acute) 
were younger than those who did not have operative intervention 
(mean age 87.8 years vs. 89.3 years, p = 0.002).
No gender differences were demonstrated between the groups 
and patients mode of presentation are shown in Table 1.
The majority of tumours (41%) were right sided (including 
hepatic flexure). Two patients presented with metachronous cancers. 
Anatomical distributions of colorectal cancers in this patient cohort 
are shown in Table 2.
The median follow up was 783 days (range 126–1985 days) for 
all patients.
Operative intervention
Ninety-three patients were managed operatively (47%). More 
than half (57%) of all patients undergoing operative intervention 
underwent right-sided resections (including hepatic flexure). The 
majority of these patients were female (60%). One fifth of patients 
underwent surgery for rectal tumours (anterior resection, total 
mesorectal excision, Hartmann’s procedure or abdominoperineal 
resection). Interestingly, the majority of these patients were male 
(70%). Two patients had a subtotal colectomy and ileostomy. Both 
these patients presented with metachronous colorectal cancers. 
Relatively few patients over the age of 85 years had a defunctioning 
stoma performed as a palliative procedure (9%). These results are 
shown in Table 3.
Of all patients who underwent operative intervention and did 
not survive, time to event (death) was much longer for those patients 
who presented non-acutely than those presenting as acute surgical 
emergencies (449 days, range 22-1507 versus 138 days, range 2-380, 
p = 0.007).
Non-operative management
A total of one hundred and six patients were managed non-
operatively. Acute and non-acute modes of clinical presentation were 
relatively equally represented in this group (47% vs. 53% respectively). 
Overall, mean survival in the emergency group (30%) was worse than 
Mode of presentation Total number(n=199) Mean age(years) % Female Overall survival
Operation
Non-Acute 72(36%) 89 52% 47(65%)
Acute 21(11%) 88 56% 11(52%)
No Operation
Non-Acute 56(28%) 89 61% 18(32%)
Acute 50(25%) 89 53% 10(20%)
Table 1: Patient demographic and operative characteristics.
Anatomical Site Number Percentage
Right 82 41%





Table 2: Anatomical distribution of colorectal cancers.
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those presenting through the elective setting (251 days vs. 561 days, 
p≤ 0.001).
Reasons for, and factors contributing to non-operative 
intervention in the management of these older patients included; 
patient choice, patients deemed to unfit for surgery, advanced stage 
disease (inoperable), other treatment modalities more appropriate 
(endoscopic stenting or palliative radiotherapy). Endoscopic 
resection was carried out in four patients presenting non-acutely with 
early colorectal cancers and endoscopic stenting performed in 16.9% 
of patients, all who presented acutely with symptoms of large bowel 
obstruction.
There was significant difference in the overall mean survival of 
patients managed non-operatively depending on mode of clinical 
presentation. Patients presenting non-acutely had a much longer 
mean survival time (348 days, range 16-1576) than those presenting 
as acute surgical emergencies (180 days, range 3-557) p = 0.03.
Outcomes of acute surgical presentation
Thirty five per cent of patients over the age of 85 years with 
colorectal cancer presented as an acute surgical emergency (56% 
female). The average of age of the patients was 88.8 years. Only 9% of all 
acute presentations underwent colonoscopy whereas 92% underwent 
an abdominal CT scan. 96% of all acute presentations were discussed 
at a multidisciplinary meeting (pre or post acute management). There 
was a clinically significant difference in mean survival time in patients 
who did or did not undergo surgical intervention, but this did not 
reach statistical significance (335 days vs. 180 days, p = 0.38). This is 
potentially due to sample size.
Outcomes of non-acute surgical presentation
Data was available for 69 out of the 72 patients who presented 
non-acutely and underwent operative intervention for their 
colorectal cancer. Mean length of stay was 10 days (range 2-35 days). 
Three patients did not survive the immediate post-operative period 
(mortality 4%). Complications were reported in 65% of patients. 
40% of these were attributable to infection (wound, chest, UTI, 
anastomotic leakor abdominal collection). 24% of complications 
were attributable to post-operative ileus. Clavien Dindo classification 
of complications is shown in Table 4.
Discussion
This study assessed outcomes after operative and non-operative 
intervention for colorectal cancer surgery in the very old. The 
study found that just over a third of all very old patients present as 
an emergency. Overall, 53% of very old patients did not undergo 
operative intervention for their bowel cancer, a figure higher than 
previously reported. Outcomes were worse for very old patients who 
presented acutely with a colorectal cancer. However, in all those 
patients that presented acutely with colorectal cancer, their time to 
death was similar irrespective of whether they underwent surgical 
intervention or not.
This is the first study to assess the outcomes for all older patients 
with colorectal cancer regardless of whether they underwent surgical 
intervention or not. Little evidence is available in the current literature 
comparing treatment options and management strategies for this 
complex group of heterogeneic and high-risk patients. Historically 
there has been a tendency to exclude very old patients from entering 
clinical trials (not just those within surgery), making evidence based 
clinical decision making more challenging [3]. The majority of 
randomised controlled trials evaluating efficacy of chemotherapy and 
surgery as treatment for colorectal cancer do not include patients 
over the age of 75 years. It is difficult, therefore, to accurately guide 
this group of patients who have been assessed as fit for surgery.
No. of patients Mean age (years) % Female
Operation Segmental resection;
Right sided 53 90 30%
Left sided 9 87 44%
Anterior resection / TME Hartmanns 20 88 30%
Abdomino-perineal resection 1 87 0%









Patient declined treatment 11 90 9(75%)
Inoperable/unfit for surgery/too risky 66 89 43(63%)
Endoscopic resection 4 88 3(75%)
Table 3: Distribution of types of cancer surgery/intervention.








Table 4: Clavien-Dindo classification of complications.
I: No Need for Treatment; II: Pharmacological Treatment; III: Requiring Surgical 
or Endoscopic or Radiological Treatment (IIIa – Not Under GA, IIIb – Under GA); 
IV: Life Threatening Complication (Iva – Single Organ Dysfunction, IVb – Mutli 
Organ Dysfunction); V: Death of a Patient
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Individualising treatment approaches for colorectal cancer 
patients presenting non-acutely affords the expertise and input of the 
multidisciplinary team. In some patients chemoradiotherapy may be 
of benefit. Recent NBOCAP data suggested that in the UK 40% of all 
colorectal cancer patients do not undergo major surgery and 22% of 
these patients are aged 80 years or older (NBOCAP 13) [9]. Previous 
studies have reported that elderly patients would be interested in 
aggressive chemotherapy regimens and the morbidity associated with 
such treatment is the same for all ages [10]. The MRC Focus 2 trial also 
showed that even frail older people where suitable for chemotherapy 
for metastatic colorectal cancer [8]. Pilot data from the FOLFIRI trial 
suggests that those with metastatic disease may obtain benefit from 
chemotherapy in terms of survival and therefore oncology input is 
also warranted. Advanced disease in this age group therefore should 
be no barrier to treatment and recruitment into trials.
However, for those patients presenting as acute surgical 
emergencies, often with physiological derangement, clinical decision 
making is challenging and treatment options limited. There is little 
available evidence upon which to base a surgical opinion of when to 
operate and when not to operate. The latter of which is invariably 
more difficult. Surgical intervention for obstructing colonic tumours 
(segmental resection or proximal defunctioning stoma) has been 
the mainstay of treatment. However, colonic stenting, which was 
previously seen as a ‘bridge’ to surgery, is becoming increasingly 
readily available for the definitive management of obstructing colonic 
tumours. A quarter of all acute presentations in our study population 
underwent colonic stenting. Our results demonstrated that patients 
who present acutely and undergo surgery do not survive longer 
that those not offered surgical resection. Sample size was small and 
there are likely to be confounding factors contributing to this, such 
as fitness for surgery and a potential survival advantage seen with a 
longer follow up period. It is possible that patients in this age group do 
not live long enough to see the survival benefit of segmental resection.
Approximately one third of our older patients underwent elective 
colorectal cancer surgery. Their immediate post-operative mortality 
was 4%. This figure is similar to previously reported all age mortality 
rates [11]. Length of stay and complication rate in this patient cohort 
was higher than previously reported for all ages of patients undergoing 
enhanced recovery surgery similar to other studies of older surgical 
patients. Pawa et al. [12] in 2011 reported an increased length of stay, 
30 day mortality and re-admission rate in octogenarians undergoing 
elective colorectal surgery. The mean age of patient in this series was 
83 years. There is some evidence to support improved outcomes for 
elective patients with pre-operative optimisation in conjunction with 
geriatricians [13].
For the remaining two thirds of patients who are not deemed fit 
enough for surgical intervention a clearer evidence based pathway 
needs to be developed. For those presenting as an emergency there 
does not appear to be a survival benefit in undergoing surgery and 
this information needs careful discussion with each patient. The poor 
prognosis following emergency presentation is well recognised in 
younger population but this important finding in the oldest old needs 
highlighting.
Our study is limited by a small sample size and single site 
data collection. However, all non-acute surgical decision making 
occurred in the context of a multi-disciplinary team, including 
surgeons, pathologists, oncologists, radiologists and colorectal 
cancer specialist nurses. We were not able to accurately establish the 
fitness of our cohort, using an established scoring system such the 
American Society of Anaesthesia (ASA) grading. Therefore we were 
not able to appropriately stratify our population leaving us to focus 
on a heterogenic population of different biological age. Our results, 
however, are in keeping with previous estimations of older people 
undergoing colorectal surgery.
It is also worth noting that we found an increased incidence of 
right sided colonic tumours (41%) compared to current published 
rates of 25% (Cancer statistics, CRUK). This finding is in keeping 
with results previously published. Hardiman et al. [6] reported, in a 
large analysis (n=10 433) of 80 year old people with colorectal cancer 
that 60% had tumours proximal to the splenic flexure, compared to 
48% in people aged under 80 years (p< 0.001). This finding has two 
implications. Firstly, right sided resectional surgery is technically less 
challenging and therefore quicker, which has anaesthetic and post-
operative implications for the frail older person. Secondly, this could 
imply different aetiology and pathophysiology in the older person 
and this finding warrants further molecular and clinical.
The proportion of older patients with a diagnosis of colorectal 
cancer will increase in the future. Currently in the UK there are 3 
million people over 80 years of age (Mid-2013 Population Estimates 
UK Office for National Statistics, 2014). The number of people over 
85 years of age in the UK is predicted to double in the next twenty 
years and nearly treble in the next thirty. Our study demonstrates 
that a third of patients in this older age group were considered fit 
enough to undergo surgical intervention for colorectal cancer. This 
fits with previous studies who have reported that 31% of men and 
25% of women aged 85 are in very good or good general health (What 
does the 2011 Census tell us about the “oldest old” living in England 
& Wales? Office for National Statistics. 2013). Previous research has 
sought to establish outcomes for the third of patients who are fit 
enough for surgery. Whilst it is encouraging to learn that older people 
can undergo such interventions as successfully as their younger 
counter parts, it is a relatively small part of the overall picture. It 
may be that the two thirds of people who are not offered surgery may 
gain positive benefit from other, non-surgical interventions such as 
endoscopic resection/stenting or treatment with chemotherapeutic 
agents. In an era of advancing surgical techniques and therapies, 
clinicians should be striving to push the boundaries. There is a need 
for large high quality, well-designed randomised clinical trials to 
improve the evidence based upon which to make decisions for this 
important group of patients with colorectal cancer.
References
1. Partnership HQI. National Bowel Cancer Audit (NBOCA). 2013.
2. Dimick JB, Cowan JA Jr, Upchurch GR Jr, Colletti LM. Hospital volume 
and surgical outcomes for elderly patients with colorectal cancer in the 
United States. J Surg Res. 2003; 114: 50-56.
3. McMurdo ME, McMurdo, Roberts H, Parker S, Wyatt N, Helen May H, 
et al. Improving recruitment of older people to research through good 
practice. Age Ageing. 2011; 40: 659-665.
4. Schiphorst AH, Pronk A, Borel Rinkes IH, Hamaker ME. Representation 
of the elderly in trials of laparoscopic surgery for colorectal cancer. 
Colorectal Dis. 2014; 16: 976-983.
5. Surgery for colorectal cancer in elderly patients: a systematic review. 
Colorectal Cancer Collaborative Group. Lancet. 2000; 356: 968-974.
6. Hardiman KM, Cone M, Sheppard BC, Herzig DO. Disparities in the 
treatment of colon cancer in octogenarians. Am J Surg. 2009; 197: 624-628.
Hewitt J, et al., Clinics in Surgery - General Surgery
Remedy Publications LLC., | http://clinicsinsurgery.com/ 2016 | Volume 1 | Article 11225
7. Smith JJ, Lee J, Burke C, Contractor KB, Dawson PM. Major colorectal 
cancer resection should not be denied to the elderly. Eur J Surg Oncol. 
2002; 28: 661-666.
8. Seymour MT, Thompson LC, Wasan HS, Middleton G, Brewster AE, 
Shepherd SF, et al. Chemotherapy options in elderly and frail patients with 
metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised 
factorial trial. Lancet. 2011; 377: 1749-59.
9. Nascimbeni R, Di Fabio F, Di Betta E, Salerni B. The changing impact of 
age on colorectal cancer surgery. A trend analysis. Colorectal Dis. 2009; 
11: 13–18.
10. Köhne CH, Folprecht G, Goldberg RM, Mitry E, Rougier P. Chemotherapy 
in elderly patients with colorectal cancer. Oncologist. 2008; 13: 390-402. 
11. Fazio VW, Tekkis PP, Remzi F, Lavery IC. Assessment of operative risk 
in colorectal cancer surgery: the Cleveland clinic foundation colorectal 
cancer model. Dis Colon Rectum. 2004; 47: 2015–2024.
12. Pawa N, Cathcart PL, Arulampalam T, Tutton MG, Motson RW. 
Enhanced recovery program following colorectal surgery in the elderly 
patient. World J Surg, 2012; 36: 415-423.
13. Indrakusuma R, Dunker MS, Peetoom JJ, Schreurs WH. Evaluation 
of preoperative geriatric assessment of elderly patients with colorectal 
carcinoma. A retrospective study. Eur J Surg Oncol. 2015; 41: 21-27.
